News
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...
5h
Zacks.com on MSNStrength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength?Lilly (LLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
The India launch of Eli Lilly’s popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
Three more states confirmed their first measles cases of the year over the weekend, as the United States battles a growing ...
5h
Zacks Investment Research on MSNLLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III StudyShares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...
GLP-1 antidiabetic drugs, which reduce body mass by 25%, impact the processed food or alcohol industry and force fashion and insurance to transform. The unwanted side effect in medicine is any ...
One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results